AJJ Medtech Holdings Limited (SGX:584)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0070
+0.0010 (16.67%)
At close: Mar 20, 2026

AJJ Medtech Holdings Income Statement

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3.192.321.620.60.32
3.192.321.620.60.32
Revenue Growth (YoY)
37.41%43.84%170.97%86.83%-53.29%
Cost of Revenue
2.021.740.920.280.05
Gross Profit
1.180.590.70.310.27
Selling, General & Admin
4.114.553.274.284.37
Other Operating Expenses
-0.1-0.07-0.06-0.08-0.18
Operating Expenses
4.024.483.214.194.19
Operating Income
-2.84-3.89-2.51-3.88-3.92
Interest Expense
-0.09-0.05-0.06-0.06-0.08
EBT Excluding Unusual Items
-2.93-3.95-2.57-3.94-3.99
Gain (Loss) on Sale of Assets
----1.88
Asset Writedown
----0.05-
Legal Settlements
----0.37
Other Unusual Items
-0.0800.01-
Pretax Income
-2.93-3.87-2.56-3.98-1.74
Income Tax Expense
0-0-0.01-0.28-0
Earnings From Continuing Operations
-2.93-3.87-2.56-3.7-1.73
Earnings From Discontinued Operations
--0.03-0.54-
Net Income to Company
-2.93-3.87-2.53-4.24-1.73
Minority Interest in Earnings
----0.04
Net Income
-2.93-3.87-2.53-4.24-1.7
Net Income to Common
-2.93-3.87-2.53-4.24-1.7
Shares Outstanding (Basic)
1,5291,367934934934
Shares Outstanding (Diluted)
1,5291,367934934934
Shares Change (YoY)
11.89%46.39%--21.32%
EPS (Basic)
-0.00-0.00-0.00-0.00-0.00
EPS (Diluted)
-0.00-0.00-0.00-0.00-0.00
Free Cash Flow
-0.78-1.62-1.74-3.24-6.04
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.01
Gross Margin
36.81%25.27%43.28%52.35%84.95%
Operating Margin
-89.00%-167.63%-155.29%-651.17%-1228.53%
Profit Margin
-91.82%-166.38%-156.47%-711.58%-531.66%
Free Cash Flow Margin
-24.28%-69.91%-107.93%-543.29%-1894.67%
EBITDA
-2.72-3.75-2.33-3.64-3.74
EBITDA Margin
-85.09%-161.60%-144.21%--
D&A For EBITDA
0.130.140.180.240.18
EBIT
-2.84-3.89-2.51-3.88-3.92
EBIT Margin
-89.00%-167.63%-155.29%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.